Pathogen burden in essential hypertension

Circulation Journal

Volumn 71, Issue 11, 2007, Pages 1761-1764

  Liu, Lijuan ^a,b   Liu, Yanbin ^c   Tong, Weijun ^c   Ye, Hong ^b   Zhang, Xianyu ^d   Cao, Wuchun ^a   Zhang, Yonghong ^c  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c SOOCHOW UNIVERSITY   (China)

^d Center for Disease Prevention and Control of Naiman Banner   (China)

Author keywords

Aggregate pathogens; Coxsackie virus; Hypertension; Risk factor

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; COXSACKIE VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; ESSENTIAL HYPERTENSION; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIAE; PATHOGENESIS; SEROPREVALENCE;

ADULT; ANTIBODIES, VIRAL; CHINA; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; COXSACKIEVIRUS INFECTIONS; CROSS-SECTIONAL STUDIES; ENTEROVIRUS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYPERTENSION; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MYCOPLASMA PNEUMONIAE; ODDS RATIO; PNEUMONIA, MYCOPLASMA; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; VIRAL LOAD;

EID: 36949028973     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.1761     Document Type: Article

References (27)

1. Fabricant CG, Fabricant J, Litrenta MM, Minick CR. Virus-induced atherosclerosis. J Exp Med 1978; 148: 335-340.
2. Hilgers KF. Monocytes/macrophages in hypertension. J Hypertens 2002; 20: 593-596.
3. Ross R. Atherosclerosis-a inflammatory disease. N Engl J Med 1999; 340: 115-126.
4. Nakanishi N, Sato M, Shiral K, Suzuki K, Tatara K. White blood cell count as risk factor for hypertension: A study of Japanese male office workers. J Hypertens 2002; 20: 851-857.
5. Patel P, Mendall MA, Carrington D, Strachan DP, Leatham E, Molineaux N, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995; 311: 711-714.
6. Niemala S, Karttunen T, Korhonen T, Laara E, Karttunen R, Ikaheimo M, et al. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart 1996; 75: 573-575.
7. Scragg RK, Fraser A, Metcalf PA. Helicobacter pylori seropositivity and cardiovascular risk factors in a multicultural workforce. J Epidemiol Community Health 1996; 50: 578-579.
8. Barnes RJ, Uff JS, Dent JC, Gear MW, Wilkinson SP. Long term follows up of patients with gastritis associated with helicobacter pylori infection. Br J Gen Pract 1991; 41: 286-288.
9. Whincup PH, Mendall MA, Perry IJ, Strachan DP, Walker M. Prospective relations between helicobacter pylori infection, coronary heart disease and stroke in middle aged men. Heart 1996; 75: 568-572.
10. Fip GYH, Wise R, Becvers G. Association between II. pylori infection and hypertension. BMJ 1996; 312: 250-251.
11. Cook PJ, Lip GYP, Davies P, Beevers DG, Wise R, Honeybourne D, Chlamydia pneumoniae antibodies in severe essential hypertension. Hypertension 1998; 31: 589-594.
12. Liu DX, Peng DX, Chen R, Lei HT, Che DY, Zhao SY. Chronic pulmonary infection caused by Mycoplasma pneumoniae leading to pulmonary arteriole remodeling and pulmonary hypertension in rats. J Tongji Med Univ 1995; 15: 223-226.
13. Sun Y, Pei W, Wu Y, Jing Z, Zhang J, Wang G. Herpes simplex virus tvpe 2 infection is a risk factor for hypertension. Hypertens Res 2004, 27: 541-544.
14. Conen D, Dieterle T, Utech K, Rimner M, Martina B. C-reactive protein and B-type natriuretic peptides in never-treated white coat hypertensive. Hypertens Res 2006; 29: 411-415.
15. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and the risk of developing hypertenison. JAMA 2003; 29: 2945-2951.
16. Schillaci G, Pirro M, Gemelli F, Pasqualini F, Vaudo G, Marchesi S. Increased C-reactive protein concentrations in never-treated hypertension: The role of systolic and pulse pressures. Hypertension 2003, 21: 1841-1846.
17. Bautista LE, Atwood JE, O'Malley PG, Taylor AJ. Association between C-reactive protein and hypertension in healthy middle-aged men and women. Coronary Heart Dis 2004, 15: 331-336.
18. Harvey R, Lane A, Murray L, Harvey I, Nair P, Donovan J. Effect of Helicobacter pylori infection on blood pressure: A community based cross sectional study. Br J Med 2001; 323: 7307.
19. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Rippin G. Impact of infectious binden on extent and long-term prognosis of atherosclerosis. Circulation 2002; 105: 15-21.
20. Zhu J, Nieto FJ, Horne BD, Anderson JF, Muhlestein JB, Epstein SE. Prospective study of pathogen binden and risk of myocardial infarction or death. Circulation 2001; 103: 45-51.
21. Rupprecht HJ, Blankenberg S, Bickel C, Rippin G, Hafner G, Prellwitz W, et al. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation 2001; 104: 25-31.
22. Clozel M. Endothelin receptor antagonists: Current status and perspectives. J Cardiovasc Pharmacol 2000; 35: S65-S68.
23. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol 2000; 130: 963-974.
24. Choy JC, Lui AH, Moien-Afshari F, Wei K, Yanagawa B, McManus BM, et al. Coxsackievirus B3 infection compromises endothelial-dependent vasodilation of coronary resistance arteries. J Cardiovasc Pharmacol 2004; 43: 39-47.
25. Kristensen BO, Andersen PL, Vestergaard BF. Herpes virus antibodies and vascular complications in essential hypertension. Acta Med Scand 1982; 212: 375-377.
26. Omura Y. Microbial infection or trauma at cardiovascular representation area of medulla oblongata as some of the possible causes of hvpertension or hypotension. Acupunct Electrother Res 1988; 13: 131-145.
27. Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S. Contribution of endothelin-1 to myocardial injury in a murine model of myocarditis: Acute effects of bosentan, an endothelin receptor antagonist. Circulation 1999; 100: 1823-1829.